The present invention relates to the use of an inhibitor for the interferon gamma signaling pathway for the preparation of a pharmaceutical composition for the treatment or prevention of restenosis. Furthermore, the present invention provides for a method for the identification of an inhibitor of the IFN- gamma signaling pathway.
